Transient nature of interference effects from heterophile antibodies: Examples of interference with cardiac marker measurements

Clinical Chemistry and Laboratory Medicine

Volumn 38, Issue 1, 2000, Pages 33-39

  Kazmierczak, Steven C ^a   Catrou, Paul G ^a   Briley, Kimberly P ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Cardiac marker measurement; Human anti murine antibodies; Interference

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE MB; HETEROPHILE ANTIBODY; IMMUNOGLOBULIN; TROPONIN I; TROPONIN T;

AGED; ARTICLE; FEMALE; HEART DISEASE; HUMAN; IMMUNOASSAY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

MURINAE;

EID: 0034026889     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2000.006     Document Type: Article

References (23)

1. Boscato LM, Stuart MC. Incidence and specificity of interference in two-site immunoassays. Clin Chem 1986; 32:1491-5.
2. Després N, Grant AM. Antibody interference in thyroid assays: a potential for clinical misinformation. [Review] Clin Chem 1998; 44:440-54.
3. Ward G, McKinnon L, Badrick T, Hickman PE. Heterophilic antibodies remain a problem for the immunoassay laboratory. Am J Clin Pathol 1997; 108:417-21.
4. Check JH, Ubelacker L, Lauer CC. Falsely elevated steroidal assay levels related to heterophile antibodies against various animal species. Gynecol Obstet Invest 1995; 40:139-40.
5. Sosolik RC, Hitchcock CL, Becker WJ. Heterophilic antibodies produce spuriously elevated concentrations of the MB isoenzyme of creatine kinase in a selected patient population. Am J Clin Pathol 1997; 107:506-10.
6. Zweig MH, Csako G, Reynolds JC, Carrasquillo JA. Interference by iatrogenically induced anti-mouse IgG antibodies in a two-site immunometric assay for thyrotropin. Arch Pathol Lab Med 1991; 115:164-8.
7. Morton BA, O'Connor-Tressel M, Beatty BG, Shively JE, Beatty JD. Artifactual CEA elevation due to human antimouse antibodies. Arch Surg 1988; 123:1242-6.
8. Price T, Beatty BG, Beatty JD, McNally AJ. Human antimurine antibody interference in measurement of carcinoembryonic antigen assessed with a double-antibody enzyme immunoassay. Clin Chem 1991; 37:51-7.
9. Schulz G, Büchler M, Muhrer KH, Klapdor R, Kübel R, Harthus HP, et al. Immunotherapy of pancreatic cancer with monoclonal antibody BW 494. Int J Cancer 1988; 41:Suppl 2:89-94.
10. Bartlett WA, Browning MCK, Jung RT. Artefactual increase in serum thyrotropin concentration caused by heterophilic antibodies with specificity for IgG of the family bovidea. Clin Chem 1986; 32:2214-9.
11. Wickus GG, Caplan RH, Mathews EA, Pehling GB. Sudden appearance and subsequent disappearance of interference in immunometric assays of thyrotropin neutralizable with purified mouse IgG. [Editorial]. Clin Chem 1991; 37:595-6.
12. 2 conjugate and polyclonal mouse IgG. Clin Chem 1992; 38:1737-42.
13. Fitzmaurice TF, Brown C, Rifai N, Wu AHB, Yeo KJ. False increases of cardiac troponin I with heterophilic antibodies. Clin Chem 1998; 44:2212-3.
14. Hasholzner U, Stieber P, Meier W, Lamerz R. Value of HAMA determination in clinical practice- an overview. Anticancer Res 1997; 17:3055-8.
15. Zweig MH, Csako G, Spero M. Escape from blocking of interfering heterophile antibodies in a two-site immunoradiometric assay for thyrotropin. Clin Chem 1988; 34:2589-91.
16. Zweig MH, Csako G, Benson CC, Weintraub BD, Kahn BB. Interference by anti-immunoglobulin G antibodies in immunoradiometric assays of thyrotropin involving mouse monoclonal antibodies. Clin Chem 1987; 33:840-4.
17. Primus FJ, Kelley EA, Hansen HJ, Goldenberg DM. "Sandwich"-type immunoassay of carcinoembryonic antigen in patients receiving murine monoclonal antibodies for diagnosis and therapy. Clin Chem 1988; 34:261-4.
18. Maita PK, Lang GM, Sehon AH. Tolerogenic conjugates of xenogenic monoclonal antibodies with monomethoxy-polyethylene glycol. I. Induction of long-lasting tolerance to xenogeneic monoclonal antibodies. Int J Cancer 1988; 41:Suppl 3:17-22.
19. Newman ES, Moskie LA, Duggal RN, Goldenberg DM, Hansen HJ. Murine monoclonal antibody adsorbed onto vinylidine fluoride floccules used to eliminate antibody interference in "sandwich"-type immunoassays. Clin Chem 1989; 35:1743-6.
20. Csako G, Weintraub BD, Zweig MH. The potency of immunoglobulin G fragments for inhibition of interference caused by anti-immunoglobulin antibodies in a monoclonal immunoradiometric assay for thyrotropin. Clin Chem 1988; 34:1481-3.
21. Niwa Y, Sakane T, Kanoh T, Shichijo S, Wiederhold MD, Yokoyama MM. Transient autoantibodies with elevated complement levels in common viral diseases. Clin Lab Immunol 1984; 13:183-8.
22. Reinsberg J. Different efficacy of various blocking reagents to eliminate interferences by human antimouse antibodies with a two-site immunoassay. Clin Biochem 1996; 29:145-8.
23. Madry N, Auerbach B, Schelp C. Measures to overcome HAMA interferences in immunoassays. Anticancer Res 1997; 17:2883-6.